Key result
NSTEMI was associated with a significantly higher risk of post-discharge death compared to STEMI (adjusted HR 1.28; 95% CI 1.14-1.44), with 2-year mortality rates of 33.2% versus 16.4%.
Why the study?
Does NSTEMI compared to STEMI increase post-discharge mortality in patients hospitalized for acute myocardial infarction?
Population
3,762 patients hospitalized with confirmed acute myocardial infarction, average age 70.3 years, 42.9% women…
Comparison
Diagnosis of non-ST-segment elevation myocardial… vs Diagnosis of ST-segment elevation myocardial…
Design
Cohort
Follow-up
up to 2 years
Authors
Loading...
Underscores need for vigilant secondary prevention in NSTEMI; leaves open whether intensified strategies improve survival.
Cohort (n=3,762)
Yes
Does NSTEMI compared to STEMI increase post-discharge mortality in patients hospitalized for acute myocardial infarction?
Hazard Ratio: 1.28 (95% CI 1.14–1.44)
Absolute Event Rate: 33.2% vs 16.4%
Patients with NSTEMI have a significantly higher risk of long-term post-discharge mortality compared to those with STEMI, highlighting the need for intensive secondary prevention in this subgroup.
Goldberg et al. (2013) conducted a cohort in Acute myocardial infarction (STEMI and NSTEMI) (n=3,762). NSTEMI vs. STEMI was evaluated on Death after hospital discharge (HR 1.28, 95% CI 1.14-1.44). NSTEMI was associated with a significantly higher risk of post-discharge death compared to STEMI (adjusted HR 1.28; 95% CI 1.14-1.44), with 2-year mortality rates of 33.2% versus 16.4%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: